Medical devices, healthcare technology and the business of care
510(k) clearance · K260108

L12 LED Light Source with AIM

Stryker Endoscopy · Decision date Feb 12, 2026

FDA DECISIONK260108

What did the FDA decide?

FDA records K260108 as a 510(k) premarket notification, with a decision dated Feb 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Feb 12, 2026

FDA source record

Regulatory record facts

Identifier
K260108
Regulatory pathway
510(k) premarket notification
Product code
OWN
Decision code
SESE
Decision date
Feb 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Confocal Optical Imaging.

Product code
OWN
FDA device class
2

FDA decision timeline

  1. K260108 received

    Application receipt date recorded by FDA.

  2. K260108 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OWN

Product / regulatory recordCompanyPathwayDecision dateSource
KALR STORZ SE & Co. KG510(k) clearanceSep 21, 2026FDA
LIMIS Development B.V.510(k) clearanceJul 24, 2026FDA
SmartsurgN, Inc.510(k) clearanceApr 20, 2026FDA
Karl Storz SE & CO. KG510(k) clearanceFeb 26, 2026FDA
VPIX MEDICAL, INC.510(k) clearanceFeb 13, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Stryker Endoscopy

Headquarters
Not reported
Brand website
stryker.com
FDA applicant address
San Jose, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records